Literature DB >> 7846463

Melatonin possesses time-dependent hypnotic effects.

O Tzischinsky1, P Lavie.   

Abstract

The present study investigated the hypnotic effects of 5 mg melatonin in comparison with placebo when administered at 1200, 1700, 1900 and 2100 hours. Eighteen young adults were studied with the 7/13 ultrashort sleep-wake paradigm after an overnight sleep deprivation. Melatonin was administered according to a double-blind Latin square design. After each administration, melatonin significantly increased sleep propensity, the spectral power in the theta, delta and spindles bands, and subjective sleepiness. It significantly decreased the power in the alpha and beta bands and oral temperature. The latency to maximum effect varied linearly from 3 hours 40 minutes at 1200 hours to 1 hour at 2100 hours. These findings indicate that melatonin possesses a time-dependent hypnotic effect and suggest that endogenous melatonin may participate in sleep-wake regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846463     DOI: 10.1093/sleep/17.7.638

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  28 in total

1.  General anesthesia for surgery influences melatonin and cortisol levels.

Authors:  Edward Ram; Tali H Vishne; Talia Weinstein; Benzion Beilin; Zeev Dreznik
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

2.  Daytime melatonin and temazepam in young adult humans: equivalent effects on sleep latency and body temperatures.

Authors:  S S Gilbert; C J van den Heuvel; D Dawson
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

3.  Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach.

Authors:  E Estrada; A Peña; R García-Domenech
Journal:  J Comput Aided Mol Des       Date:  1998-11       Impact factor: 3.686

Review 4.  Melatonin, sleep, aging, and the health protection branch.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

5.  Use of transdermal melatonin delivery to improve sleep maintenance during daytime.

Authors:  D Aeschbach; B J Lockyer; D-J Dijk; S W Lockley; E S Nuwayser; L D Nichols; C A Czeisler
Journal:  Clin Pharmacol Ther       Date:  2009-07-15       Impact factor: 6.875

6.  Sleep, Hormones, and Circadian Rhythms throughout the Menstrual Cycle in Healthy Women and Women with Premenstrual Dysphoric Disorder.

Authors:  Ari Shechter; Diane B Boivin
Journal:  Int J Endocrinol       Date:  2010-01-18       Impact factor: 3.257

Review 7.  Medication for sleep-wake disorders.

Authors:  G Stores
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

8.  Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.

Authors:  Glenna A Dowling; Robert L Burr; Eus J W Van Someren; Erin M Hubbard; Jay S Luxenberg; Judy Mastick; Bruce A Cooper
Journal:  J Am Geriatr Soc       Date:  2007-12-07       Impact factor: 5.562

9.  Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance.

Authors:  Stephanie J Crowley; Charmane I Eastman
Journal:  Psychopharmacology (Berl)       Date:  2012-09-22       Impact factor: 4.530

Review 10.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.